Proxsys Rx, an integrated outpatient pharmacy provider, said Thursday it now offers an end-to-end solution to hospitals to help them comply with all aspects of the 340B program.
Drugmakers need to provide eligible organizations with certain prescription drugs at significantly reduced prices under the federally mandated 340B program. The organizations then contract with outpatient pharmacies to dispense the drugs to eligible patients who meet the program's criteria.
"Hospitals are able to dramatically reduce their 340B costs and enhance proper utilization by implementing Proxsys Rx solutions,” Proxsys Rx CEO George B. Salem said. “They are also partnering with a seasoned team of professionals who have decades of experience navigating the intricacies of the regulatory system."
The Proxsys Rx model enables the health care facility to manage 340B operations better by decreasing the uncertainties related to program participation, cost and pricing. RxPreferred Benefits provides Proxsys Rx with management support.
Proxsys Rx delivers hospitals software tools and pharmacy integration programs to improve their 340B program status and performance. When a hospital or health care system implements the Proxsys Rx 340B solution, they use the Proxsys Rx program’s real time management tools for enrollment, eligibility and reporting that will support the requirements of an audit. Other features include inventory management, invoicing and automated drug replenishment.